Viewing Study NCT05586958


Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2026-01-04 @ 4:13 PM
Study NCT ID: NCT05586958
Status: COMPLETED
Last Update Posted: 2025-10-29
First Post: 2022-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Sponsor: LG Chem
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module